Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. - Wikidata - awgldk - TriplyDB

Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.

Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.

http://www.wikidata.org/entity/Q36861712

about

Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells Stem cells in plastic surgery: a review of current clinical and translational applications Pluripotent stem cells: immune to the immune system?Immunogenicity and tumorigenicity of pluripotent stem cells and their derivatives: genetic and epigenetic perspectives The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies Stem cell imaging: from bench to bedside The benefits and risks of stem cell technology Imaging: guiding the clinical translation of cardiac stem cell therapy Induced pluripotent stem cell potential in medicine, specifically focused on reproductive medicine Banking on iPSC--is it doable and is it worthwhile Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation Generation of novel reporter stem cells and their application for molecular imaging of cardiac-differentiated stem cells in vivo.Cardiovascular molecular imaging: focus on clinical translation Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging.Multimodal in vivo imaging reveals limited allograft survival, intrapulmonary cell trapping and minimal evidence for ischemia-directed BMSC homing.nAChRs mediate human embryonic stem cell-derived endothelial cells: proliferation, apoptosis, and angiogenesis Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells.Age-related decreases of serum-response factor levels in human mesenchymal stem cells are involved in skeletal muscle differentiation and engraftment capacity Comparison of immunopathology and locomotor recovery in C57BL/6, BUB/BnJ, and NOD-SCID mice after contusion spinal cord injury Cell-based therapy for heart disease: a clinically oriented perspective Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain.The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives.Human stem cells for craniomaxillofacial reconstruction.The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications Options for tracking GFP-Labeled transplanted myoblasts using in vivo fluorescence imaging: implications for tracking stem cell fate A mystery unraveled: nontumorigenic pluripotent stem cells in human adult tissues Gene correction in human embryonic and induced pluripotent stem cells: promises and challenges ahead.Non-invasive imaging of human embryonic stem cells.Cell replacement therapies to promote remyelination in a viral model of demyelination Harnessing the potential of induced pluripotent stem cells for regenerative medicine.Twisting immune responses for allogeneic stem cell therapy Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.Baculovirus as an ideal radionuclide reporter gene vector: a new strategy for monitoring the fate of human stem cells in vivo.Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells.Interaction of a specific population of human embryonic stem cell-derived progenitor cells with CD11b+ cells ameliorates sepsis-induced lung inflammatory injury.Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges Multimodality molecular imaging of stem cells therapy for stroke Functional integration of human neural precursor cells in mouse cortex.In vivo bioluminescence for tracking cell fate and function.A new chapter: hematopoietic stem cells are direct players in immunity.

P2860

Q21134034-A806BD98-DDAC-4492-9C5F-CBDE4D36022A Q26821935-9203F231-8C31-4A1D-8182-FE3C14429E67 Q26823255-FD2705C7-6074-4CB4-9748-B78112B7944D Q26849530-9D4A3D15-5F8F-485C-8A39-8AAD4DFF6D9A Q26851666-F163D9AF-ED6B-4C65-98C8-1DE5D5C0026F Q26861615-164EDA62-C4F4-46EA-BEEE-14BC311E14BA Q26864641-3793A62F-B76B-43AE-91CC-9F375972A615 Q27008410-1AA1C79F-70D0-4156-BF0D-93A32D270DB1 Q28083057-6548EA10-97C9-4BC5-BEF6-A81BE20C6B78 Q28254023-04E73F1F-9C71-4C13-9D3D-ECC576A84339 Q28543575-8A4BC8D8-9BDB-4233-BF61-81DEF8486648 Q30430937-F6289D8E-16D7-447D-97C6-9E592928ADA7 Q30470859-59D39B6C-48A6-4084-B412-ACACEBDAA936 Q30529647-12121E99-0005-4DC5-8ACA-A21F756A3810 Q30530998-AF70F63E-A05F-4AB0-8003-A88FC798F5D9 Q33503262-1D151CE2-C239-4F65-965D-309BE136A925 Q33529091-A854A190-B452-4DF9-98C1-E8CD843FF42C Q33637253-53D2C1C4-DEC2-4DB3-8E50-DC5553372883 Q33710820-A5619F88-5E9D-464B-AF21-C69FA64D0BFC Q33713519-39542D4D-CF80-4A52-9F31-383B1C57902C Q33713837-A86281A4-18BC-40F2-A200-5754EDEDDA1D Q33753295-099E4D02-7556-4132-9D4F-3CB9C08DC643 Q33788845-4496E0A8-7BFD-417D-91E4-59F4C54C79D3 Q33851544-F7E334BE-1855-4EDD-8112-76A61D7E08B3 Q33898074-AD906772-D24E-427F-A165-96FAE8FDC2E1 Q33911166-A357DC1E-22D7-4FB5-B29A-E55579DEF831 Q33930103-AE098EAA-9832-479D-82A0-7C3AEBCE10FD Q34050057-4320D502-6E42-479D-9BD8-009E304987FB Q34056814-6A1112CF-C774-4078-BF0E-1A1BD433DC30 Q34182222-19649165-D720-41EB-80E6-A9718757F219 Q34216801-DD679F73-7181-42BE-90FB-D8E1F8D4FFE7 Q34245487-9E5A343E-C2A1-42C7-A9A4-BD6A25D010CB Q34676290-352D7196-ECD9-411B-8D5A-894533172E85 Q34700964-572D77FE-142E-4E8D-A628-348C9F83AEFA Q34756250-CCB1FEA4-9EB1-418B-BCCD-8EAF2270A660 Q34981433-B8ACB1A3-A618-483D-BD96-C432F3A73329 Q35040022-905FB901-C676-421A-9E0C-409CCC7BA475 Q35170863-13CA4691-2F70-4C8E-A6EC-1BC598720648 Q35314819-6373E402-C73F-4DF8-8049-451AA6E3BD76 Q35412882-A5227D17-0890-41E1-B8AA-67022FC16F82

P2860

Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.

http://www.wikidata.org/entity/Q36861712

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Immunosuppressive therapy miti ...... mbryonic stem cell xenografts.

@en

type

label

Immunosuppressive therapy miti ...... mbryonic stem cell xenografts.

@en

prefLabel

Immunosuppressive therapy miti ...... mbryonic stem cell xenografts.

@en

P1433

Q36861712-77619AB8-2DD6-431D-8D30-855602727128

P1476

Q36861712-150627B9-FB2A-482C-B58E-D51C34F8DB7A

P2093

Q36861712-11CB5BEF-046E-4845-86D4-7181720CF044

Q36861712-57732EB5-E9DB-4449-9601-8B9ECD9A69F9

Q36861712-72819304-32FD-4FDC-99F5-AA1DADF75F4B

Q36861712-7A23B6D0-F583-4CB3-810B-309CD65AA118

Q36861712-AA5291E1-8EE4-457F-B6AF-248C036396B2

Q36861712-B678A54A-2178-4F7B-A495-3450423513B3

Q36861712-C12DF8F6-4AE4-428D-87E4-2BFAC0C1B0C0

Q36861712-D9BB1A78-6AE2-4D83-9230-372B24E644BE

Q36861712-E46CE44D-D8C1-4E04-8510-1834C015D775

P2860

Q36861712-1C6BC004-D7D9-4B4E-8BC6-F0075671ED8C

Q36861712-2E2C9ADA-AD84-431A-AB5D-8107C547AD34

Q36861712-2FC1764E-73D3-4C4F-B76B-80798E3D45C1

Q36861712-3D8F4C71-C195-4DF1-B4D1-A7AAFE1526C3

Q36861712-45390A28-D731-4E23-8DF1-FC33EF2A0EC0

Q36861712-4784D72F-F2F5-424D-99C7-3273B72DAE11

Q36861712-52DCD538-8385-4ADF-9EA8-457B73202518

Q36861712-567497DB-C2DA-41FE-BB4E-51498D4FCAEB

Q36861712-62471C8F-3B46-47EA-A030-706ED1CFDCEB

Q36861712-6CFD829B-7464-441C-B520-134F23D8F57D

P304

Q36861712-0C864944-649F-4263-885A-BDB172FA5010

P31

Q36861712-743B4B31-3612-429F-B9DB-01A3B527F56D

P356

Q36861712-951E1961-6C83-4566-9819-5F063BCF0BBE

P407

Q36861712-457EF51E-C455-465F-915F-4F7A71750420

P433

Q36861712-4AA9CB53-8391-4371-B070-4E2D01B4BB75

P478

Q36861712-3A6FA6C6-5499-4DBE-AB72-DAAD717EDD3D

P50

Q36861712-108B770C-A3BA-4A60-A4EA-FFBEC8D0D4AE

Q36861712-A5EABE4D-8C3B-4801-A5CF-A96C2C1DC552

P577

Q36861712-37C93EC6-6FEA-4E2B-ADAF-E209155D8FB3

P5875

Q36861712-C0C8BAC0-CCF3-4B4C-A742-309BB24EC86F

P698

Q36861712-CDFFFF56-845A-4A84-910D-F308A20F05F9

P921

Q36861712-C156AD7B-390C-4059-AC13-EBDEE7C8F94C

P932

Q36861712-1D3FD4A9-FC0D-4734-9BE6-DE977ABE0EF0

P356

PNAS.0805802105

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Immunosuppressive therapy miti ...... mbryonic stem cell xenografts.

@en

P2093

Ahmad Y Sheikh

http://www.w3.org/2001/XMLSchema#string

Andrew J Connolly

http://www.w3.org/2001/XMLSchema#string

Feng Cao

http://www.w3.org/2001/XMLSchema#string

Johannes A Govaert

http://www.w3.org/2001/XMLSchema#string

Katie Ransohoff

http://www.w3.org/2001/XMLSchema#string

Mark M Davis

http://www.w3.org/2001/XMLSchema#string

Munif Haddad

http://www.w3.org/2001/XMLSchema#string

Rutger-Jan Swijnenburg

http://www.w3.org/2001/XMLSchema#string

Sonja Schrepfer

http://www.w3.org/2001/XMLSchema#string

P2860

In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery

Embryonic stem cell lines derived from human blastocysts

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

Responsible oversight of human stem cell research: the California Institute for Regenerative Medicine's medical and ethical standards.

Characterization of the expression of MHC proteins in human embryonic stem cells.

Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.

Pathways of allorecognition: implications for transplantation tolerance.

Stem cell medicine encounters the immune system.

Shifting foci of hematopoiesis during reconstitution from single stem cells

P304

12991-12996

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0805802105

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

Robert C. Robbins

P577

2008-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23194884

http://www.w3.org/2001/XMLSchema#string

P698

18728188

http://www.w3.org/2001/XMLSchema#string

P921

P932

2529073

http://www.w3.org/2001/XMLSchema#string